1nhaler
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$4.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
1nhaler is a medical device company that is a developer of a single-dose, disposable, dry-powder inhaler.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1nhaler Comparables
Compare 1nhaler with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merxin Ltd | 78% | |
| PureIMS | 77% | |
| AptarGroup | 73% |
1nhaler Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 | ||||
| Seed | Nov 27, 2023 |
1nhaler Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scottish Investment Bank (Scottish Enterprise) | Seed |
| British Business Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$2M round with British Business Investments and Scottish Investment Bank.
- Nov 27, 2023
$2.5M raised from British Business Investments and Dr Yusuf Hamied.
1nhaler Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 1nhaler's valuation, stock price, and market status.
Is 1nhaler a public or private company?
1nhaler is a private company.
What is the current stock price of 1nhaler?
1nhaler is a private company with no public stock price. No recent secondary market data is available.
How much is 1nhaler worth (valuation)?
Valuation information for 1nhaler is not publicly available.
Can I buy 1nhaler stock?
1nhaler shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 1nhaler's last funding round?
1nhaler's most recent funding round was Seed on November 17, 2025.
Who are the main investors in 1nhaler?
Key investors in 1nhaler include Scottish Investment Bank (Scottish Enterprise), British Business Investments.
Will 1nhaler IPO soon?
No public IPO plans have been announced for 1nhaler.
How can I track 1nhaler secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 1nhaler's secondary market activity and sign up for updates.